(Q28196757)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12867250%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

review article

1 reference

title

Utility of inflammatory markers in the management of coronary artery disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12867250%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

main subject

inflammation

0 references

coronary artery disease

1 reference

Robert S Rosenson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12867250%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Wolfgang Koenig

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12867250%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 July 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12867250%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12867250%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12867250%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

1A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12867250%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

10i-8i

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12867250%20AND%20SRC:MED&resulttype=core&format=json

Acute-phase reactants and coronary heart disease

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

High-sensitivity C-reactive protein and cardiovascular risk in patients with coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

The pathogenesis of atherosclerosis: a perspective for the 1990s

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Chemokines--chemotactic cytokines that mediate inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Strategies to achieve coronary arterial plaque stabilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Association of coronary plaque rupture and atherosclerotic inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Acute-phase proteins and other systemic responses to inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Myocardial injury: the acute phase response and lipoprotein metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Control of plasma fibrinogen levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Fibrinogen is a predictor of mortality in coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Fibrinogen as a risk factor for coronary heart disease and mortality in middle-aged men and women. The Scottish Heart Health Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Enhanced Inflammatory Response to Coronary Angioplasty in Patients With Severe Unstable Angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Independent prognostic value of elevated C-reactive protein in unstable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Elevated Levels of Interleukin-6 in Unstable Angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Inflammatory status as a main determinant of outcome in patients with unstable angina, independent of coagulation activation and endothelial cell function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB Trial)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Incremental prognostic value of serum levels of troponin T and C-reactive protein on admission in patients with unstable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Cardiac release of cytokines and inflammatory responses in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Induction of interleukin-6 synthesis in the myocardium. Potential role in postreperfusion inflammatory injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Induction of cytokine expression in leukocytes in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

[Rapid physiological coagulation method in determination of fibrinogen]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Intraindividual variability of fibrinogen levels and cardiovascular risk profile.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Retest reliability of plasma cholesterol and triglyceride. The Lipid Research Clinics Prevalence Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Variability in fibrinogen measurements: an obstacle to cardiovascular risk stratification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Fibrinogen, viscosity and the 10-year incidence of ischaemic heart disease: The Caerphilly and Speedwell Studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Association of Fibrinogen With Cardiovascular Risk Factors and Cardiovascular Disease in the Framingham Offspring Population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

High sensitivity C-reactive protein: biological variations and reference limits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Fibrinogen as a risk factor for stroke and myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Elevated C-reactive protein levels in overweight and obese adults

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Serum levels of C-reactive protein are associated with obesity, weight gain, and hormone replacement therapy in healthy postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

von Willebrand Factor, C-Reactive Protein, and 5-Year Mortality in Diabetic and Nondiabetic Subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Association between C-reactive protein and features of the metabolic syndrome: a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Antithrombin III and fibrinogen as predictors of cardiac events in patients with angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Inhibition of proinflammatory cytokine production by pravastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Antiatherothrombotic properties of statins: implications for cardiovascular event reduction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Comparative study of HMG-CoA reductase inhibitors on fibrinogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia. Atorvastatin Study Group I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Treatment of severe hypertriglyceridemia lowers plasma viscosity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Results of two clinical trials on the safety and efficacy of pravastatin 80 and 160 mg per day.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Comparison of effect of intensive lipid lowering with atorvastatin to less intensive lowering with lovastatin on C-reactive protein in patients with stable angina pectoris and inducible myocardial ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Both fenofibrate and atorvastatin improve vascular reactivity in combined hyperlipidaemia (fenofibrate versus atorvastatin trial--FAT).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900504-6

10.1016/S0002-9149(03)00504-6

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12867250%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference